Thibaut started his career as a scientist with a US biotech company developing cancer immunotherapeutics.

In 2005 he joined Bioam Gestion, a venture capital firm investing in life science companies. In 2010, Bioam merged with Bpifrance Investissement (formerly known as CDC Entreprises), a leading French investment firm investing in SMEs and mid-Tier companies. He is in charge of managing investments in life sciences companies (Seed, Venture, IPO, PIPE).

Thibaut is a graduate of the Ecole Centrale de Paris and holds a PhD from the Pierre & Marie Curie University.


Our board of directors is made up of seasoned industry investors and executives who provide their leadership and experience as we progress our promising pipeline into the clinic.